CAS No. 1239908-20-3
Batch:
Purity:99.63
Chemical Structure
Check the
Ixazomib Citrate (MLN9708)
product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.
| CAS Number | 1239908-20-3 | |
|---|---|---|
| Molecular Formula |
C20H23BCl2N2O9 |
|
| Molecular Weight (MW) | 517.12 | |
| SMILES | CC(C)CC(NC(=O)CNC(=O)C1=C(Cl)C=CC(=C1)Cl)B2OC(=O)C(CC(O)=O)(CC(O)=O)O2 |
Ixazomib Citrate (MLN9708) is an orally bioavailable prodrug of Ixazomib (MLN2238), a selective 20S proteasome inhibitor targeting the chymotrypsin-like β5 site,, caspase-like β1 site, and trypsin-like β2 site. Inhibition of proteasomal degradation blocks NF-κB pathway activation and suppresses downstream cell survival signaling, ultimately inducing apoptosis in target cells. [1]
|
Concentration
Volume
Mass
|
|---|
Batch:
All in vitro solubility values are batch-tested experimental data (non-literature values).
| Solvent | Solubility & Note |
|---|---|
| DMSO |
100 mg/mL
(193.37 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Ethanol | 25 mg/mL |
| Water | Insoluble |
Q: Why does a DMSO stock precipitate in media/saline?
A: It is caused by unheated aqueous media (supersaturation), local solvent shock, or incorrect mixing sequence.
How to fix it?
- Preheat media/saline to 37°C.
- Mix rapidly (pipette/vortex) upon addition.
- For complex mixes, always add the aqueous phase last.
- Re-dissolve minor precipitates with a 37°C water bath and sonication (≤30 min).
- Ixazomib Citrate (MLN9708) Clinical Trials
- Ixazomib Citrate (MLN9708) Solubility in DMSO
- Ixazomib Citrate (MLN9708) Stock Solution
- Ixazomib Citrate (MLN9708) Storage
- Ixazomib Citrate (MLN9708) Stability
- Ixazomib Citrate (MLN9708) Molecular Weight
- Ixazomib Citrate (MLN9708) SMILES
- Ixazomib Citrate (MLN9708) Chemical Structure (2D and 3D)
- Ixazomib Citrate (MLN9708) SDS｜MSDS
Note: Technical data last updated: Sep 1, 2026.